Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000899243-21-020989

Options or other derivatives

  • Director acquired 19,596 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Klein Lawrence Otto Director 2021-05-26 Grant or award · Stock Option (right to buy) +19,596 19,596 D
Loading xslF345X03/doc4.xml…